Mesothelioma
Advertisement
A multicenter study that included 21,062 patients who were seen from 2009-2021 in South Korea provided key insights.
Christopher Seder, MD, discusses the database and how it can be used for research, quality improvement, and risk ...
Despite decades of decline, "lung cancer continues to dwarf other cancers in the number of deaths," officials said.
The foundation's 2024 Scientific Grant Program awards mark the "largest single-year investment in its history.”
A new study illustrated the importance of exercise for patients with lung cancer who experience cancer-related fatigue.
Certain groups continue to experience higher rates of lung cancer mortality related to chronic lower respiratory diseases.
Researchers evaluated the immunogenicity and safety of the COVID-19 vaccine in patients with lung cancer.
The recent report shows that the "breadth of tobacco-caused disparities continues to persist and expand."
The last Surgeon General’s report on tobacco-related disparities was released more than two decades ago in 1998.
A project led by a researcher from the Dana-Farber Cancer Center is the first to receive the four-year grant of $2.5 million.
Deborah Brown shares key findings from the recently released seventh annual "State of Lung Cancer" report.
The campaign kicked off on November 1 to coincide with Lung Cancer Awareness Month.
Deborah Brown shares how the American Lung Association and its LUNG FORCE initiative are raising awareness this month.
Dr. Studts discusses why Lung Cancer Awareness Month is a critical time to inspire action, engagement, and hope.
The initiative is promoting lung cancer screening and efforts to fund research, as well as releasing an upcoming report.
Researchers conducted an extensive analysis of PM2.5 exposure based on residential history, satellite data, and more.
Lung Cancer Awareness Month is observed every November and represents a key time to take action and raise awareness.
The campaign, titled "Anyone with Lungs Can Get Lung Cancer," includes multiple virtual and in-person components.
Arthi Sridhar, MD, discusses the real-world study, which was presented at the IASLC 2024 World Conference on Lung Cancer.
Learn what the global survey showed about the rates of biomarker testing and the remaining barriers to implementation.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.